Pentaglobin as an adjunct therapy in very low birthweight neonates with nosocomial sepsis

Journal of the Pakistan Medical Association

Volumn 63, Issue 11, 2013, Pages 1353-1357

  Salihoglu, Özgül ^a   Can, Emrah ^a   Özberk Koç, Melike ^b   Durmus, Eda ^b   Hatipoglu, Sami ^b  

^a Zeynep Kamil Hospital Neonatal Intensive Care Unit   (Turkey)

^b BAKIRKOY DR SADI KONUK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

NICU; Nosocomial sepsis; Pentaglobin; Very low birthweight

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; IMMUNOGLOBULIN G;

ABSENCE OF SIDE EFFECTS; ADJUVANT THERAPY; ARTERIAL PRESSURE; ARTICLE; BACTERIUM CULTURE; BLEEDING; BLOOD CULTURE; BLOOD OXYGEN TENSION; BLOOD SMEAR; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTINUOUS INFUSION; ENCEPHALOMALACIA; FEMALE; HEMOLYSIS; HOSPITAL INFECTION; HUMAN; INTERVENTION STUDY; KLEBSIELLA PNEUMONIAE; MALE; NECROTIZING ENTEROCOLITIS; NEUTROPHIL; NEWBORN; NEWBORN MORBIDITY; NEWBORN SEPSIS; PATENT DUCTUS ARTERIOSUS; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; VERY LOW BIRTH WEIGHT;

EID: 84886418176     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Chirico G, Cortinovis S, Fonte C, Giudici G. Bacterial sepsis. J Chemother 2007; 19: 28-30.
2. Heath JA, Zerr DM. Infections acquired in the nursery: epidemiology and control. In: Remington JS, Klein JO, Wilson CB, Baker CJ (eds). Infectious Diseases of the Fetus and Newborn Infant. 6th ed. Philadelphia, PA: Elsevier Saunders; 2006; pp 1179-205.
3. Weinberg GA, D'Angio CT. Laboratory aids for diagnosis of neonatal sepsis. In: Remington JS, Klein JO, Wilson CB, Baker CJ (eds). Infectious Diseases of the Fetus and Newborn Infant. 6th ed. Philadelphia, PA: Elsevier Saunders; 2006; pp 1207-22.
4. Gordon A, Jeffery HE. Antibiotic regimens for suspected late onset sepsis in newborn infants. Cochrane Database Syst Rev 2005: CD004501.
5. Cohen S, Porter RR. Structure and biological activity of immunoglobulins. Adv Immunoglob 1964; 4: 287-349.
6. Jenson HB, Pollock BH. Meta-analyses of the effectiveness of intravenous immune globulin for prevention and treatment of neonatal sepsis. Pediatrics 1997; 99: E2.
7. Ohlsson A, Lacy JB. Intravenous immunoglobulin for preventing infection in preterm and/or very low birth weight infants. Cochrane Database Syst Rev 2007:CD000361.
8. Ohlsson A, Lacy JB. Intravenous immunoglobulin for suspected or subsequently proven infection in neonates. Cochrane Database Syst Rev 2010: CD001239.
9. Kreymann KG, de Heer G, Nierhaus A, Kluge S. Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock. Crit Care Med 2007; 35: 2677-85.
10. Carey AJ, Saiman L, Polin RA. Hospital-acquired infections in the NICU: epidemiology for the new millennium. Clin Perinatol 2008; 35: 223-49.
11. National Committee for Clinical Laboratory Standards. Analysis and Presentation of Cumulative Antimicrobial Susceptibility Testing Data; Proposed Guideline. NCCLS document M39-P. Wayne, PA: NCCLS; 2002.
12. American Academy of Pediatrics. Report of the Committee on Infectious Disease 2007-2009. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009.
13. Palazzi DL, Klein JO, Baker CJ. Bacterial sepsis and meningitis. In: Remington JS, Klein JO, Wilson CB, Baker CJ (eds.). Infectious Diseases of the Fetus and Newborn Infant. 6th ed. Philadelphia, PA: Elsevier Saunders; 2006; pp 247-95.
14. Haque KN, Remo C, Bahakim H. Comparison of two types of intravenous immunoglobulins in the treatment of neonatal sepsis. Clin Exp Immunol 1995; 101: 328-33.
15. Weisman LE, Cruess DF, Fischer GF. Standard versus hyperimmune intravenous immunoglobulin in preventing or treating neonatal bacterial infection. Clin Perinatol 1993; 20: 211-24.
16. Noya FJD, Baker CJ. Intravenously administered immunoglobulin for preterm infants: a time to wait. J Pediatr 1989; 115: 969-71.
17. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008; 34: 17-60.
18. El-Nawawy A, El-Kinany H, Hamdy El-Sayed M, Boshra N. Intravenous polyclonal immunoglobulin administration to sepsis syndrome patients: a prospective study in a pediatric intensive care unit. J Trop Pediatr 2005; 51: 271-8.
19. INIS Collaborative Group, Brocklehurst P, Farrell B, King A, Juszczak E, Darlow B, et al. Treatment of neonatal sepsis with intravenous immune globulin. N Engl J Med 2011; 365: 1201-11.
20. Bernier GM. Immunology. In: Bellanti JA (ed.). Immunology II. 2nd ed. Philadelphia, PA: W Saunders Co., 1985; pp 89-105.
21. Ziegler EJ, McCutchan JA, Fierer J, Glauser MP, Sadoff JC, Douglas H, et al. Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med 1982; 307: 1225-30.
22. Kilani RA, Basamad M. Pattern of proven bacterial sepsis in a neonatal intensive care unit in Riyadh-Saudi Arabia: a 2-year analysis. J Med Liban 2000; 48: 77-83.
23. Malik A, Hasani SE, Khan HM, Ahmad AJ. Nosocomial infections in newborns. Indian Pediatr 2001; 38: 68-71.
24. Karthikeyan G, Premkumar K. Neonatal sepsis: Staphylococcus aureus as the predominant pathogen. Indian J Pediatr 2001; 68: 715-7.
25. Anwer SK, Mustafa S, Pariyani S, Ashraf S, Taufiq KM. Neonatal sepsis: an etiological study. J Pak Med Assoc 2000; 50: 91-4.
26. Copelan EA, Strohm PL, Kennedy MS, Tutschka PJ. Hemolysis following intravenous immune globulin therapy. Transfusion 1986; 26: 410-2.